Stay Alert for Switches to Rytary From Other Carbidopa/Levodopa Products

July 2015

You'll see Rytary (rye-TAR-ee), which is a new extended-release formulation of carbidopa/levodopa for Parkinson's disease.

Think of Rytary as having the benefits of both carbidopa/levodopa immediate-release (Sinemet) and sustained-release (Sinemet CR).

It starts to work within about an hour, similar to carbidopa/levodopa IR...but lasts longer, similar to carbidopa/levodopa CR.

Practical advice for a better career, with unlimited access to CE

Pharmacy Technician's Letter includes:

12 issues every year, with brief articles about new meds and hot topics
120+ CE courses, including the popular CE-in-the-Letter
Helpful, in-depth Technician Tutorials
Access to the entire archive

Subscribe Today!

Already a subscriber? Log in

Volume pricing available. Get a quote

Table of Contents

CMRs Help Identify Potential Comprehensive Med Review Candidates
E-Prescriptions Stay Alert for Multiple Transmittals of the Same e-Rx
Parkinson's Disease Stay Alert for Switches to Rytary From Other Carbidopa/Levodopa Products
Generics Don't Automatically Substitute Between Aripiprazole Dosage Forms
Probiotics Point out the "Directions for Use" Section on Probiotic Products
Fentanyl Patches Help Ensure Patients Prescribed Fentanyl Have Used Other Opioids Before
Bites & Stings Watch for New Graphics on Insect Repellent Labeling
Naloxone Watch Ingredients and Supplies Closely When Preparing Naloxone Kits
Supplements Watch for Mix-Ups Between Niacinamide and Other Vitamin B3 Forms
Diabetes Meds Listen for Patients on a "Flozin" Talking About Sudden Illness
Communication Include Pictograms With Pharmacy Paperwork